Real-time enrollment status for this metastatic nsclc - non-small cell lung cancer clinical trial
Current Status
Recruiting
Checked: November 5, 2026 at 5:05 PM UTC
| NCT Number | NCT07688577 |
| Recruiting Status | Recruiting |
| Condition | Metastatic NSCLC - Non-Small Cell Lung Cancer |
| Phase | PHASE1 |
| Target Enrollment | 180 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Xilio Development, Inc. |
| Last Updated on CT.gov | November 4, 2026 (Yesterday) |
As of November 5, 2026: Clinical trial NCT07688577 is currently recruiting participants. This phase1 study for metastatic nsclc - non-small cell lung cancer is actively seeking new participants at 3 locations across the United States. The study is sponsored by Xilio Development, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07688577 is actively recruiting participants as of November 5, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07688577 was last updated Yesterday (November 4, 2026). HelloStudys verifies this status automatically.